The Mammalian Choroid Plexus, Scientific American, vol.261, issue.5 ,
DOI : 10.1038/scientificamerican1189-68
Encyclopedia of Life Sciences, 2001. ,
Influences of Blood Sample Processing on Low-Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry, Clinical Chemistry, vol.51, issue.9, pp.1637-1649, 2005. ,
DOI : 10.1373/clinchem.2005.051417
Assessment Approach for Evaluating High Abundance Protein Depletion Methods for Cerebrospinal Fluid (CSF) Proteomic Analysis, Journal of Proteome Research, vol.6, issue.9, pp.3739-3751, 2007. ,
DOI : 10.1021/pr070293w
Protein Analysis in Human Cerebrospinal Fluid: Physiological Aspects, Current Progress and Future Challenges, Disease Markers, vol.22, issue.1-2, pp.3-26, 2006. ,
DOI : 10.1155/2006/158797
Evaluation of Protein Depletion Methods for the Analysis of Total-, Phospho- and Glycoproteins in Lumbar Cerebrospinal Fluid, Journal of Proteome Research, vol.4, issue.3, pp.837-845, 2005. ,
DOI : 10.1021/pr049750o
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, pp.734-746, 2007. ,
DOI : 10.1016/S1474-4422(07)70178-3
CSF markers for incipient Alzheimer's disease, The Lancet Neurology, vol.2, issue.10, pp.605-613, 2003. ,
DOI : 10.1016/S1474-4422(03)00530-1
Cerebrospinal fluid tau and ??-amyloid in Alzheimer patients, disease controls and an age-matched random sample, Neurobiology of Aging, vol.27, issue.9, pp.1202-1211, 2006. ,
DOI : 10.1016/j.neurobiolaging.2005.06.005
CSF A??42, Tau and phosphorylated Tau, APOE ??4 allele and MCI type in progressive MCI, Neurobiology of Aging, vol.28, issue.4, pp.507-514, 2007. ,
DOI : 10.1016/j.neurobiolaging.2006.02.001
Abnormal Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt???Jakob Disease, New England Journal of Medicine, vol.315, issue.5, pp.315-279, 1986. ,
DOI : 10.1056/NEJM198607313150502
Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid, The Lancet, vol.348, issue.9031, pp.846-849, 1996. ,
DOI : 10.1016/S0140-6736(96)08077-4
The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies, New England Journal of Medicine, vol.335, issue.13, pp.924-930, 1996. ,
DOI : 10.1056/NEJM199609263351303
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study, Brain, vol.122, issue.11, pp.2047-2056, 1999. ,
DOI : 10.1093/brain/122.11.2047
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event, New England Journal of Medicine, vol.349, issue.2, pp.139-145, 2003. ,
DOI : 10.1056/NEJMoa022328
Proteins of the Cerebrospinal Fluid, pp.13-31, 2005. ,
Proteomics of Alzheimer???s disease: understanding mechanisms and seeking biomarkers, Expert Review of Proteomics, vol.293, issue.2, pp.227-238, 2007. ,
DOI : 10.1006/bbrc.2002.6678
Between-gel reproducibility of the human cerebrospinal fluid proteome, PROTEOMICS, vol.3, issue.10, pp.1962-1979, 2003. ,
DOI : 10.1002/pmic.200300463
Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid, Molecular & Cellular Proteomics, vol.9, issue.12, 2000. ,
DOI : 10.1002/ana.20009
Human cerebrospinal fluid peptidomics, Journal of Mass Spectrometry, vol.308, issue.2, pp.176-181, 2005. ,
DOI : 10.2174/1386207013331246
Proteomics analysis of human cerebrospinal fluid, Journal of Chromatography B, vol.815, issue.1-2, pp.179-189, 2005. ,
DOI : 10.1016/j.jchromb.2004.06.044
Proteomics analysis of prefractionated human lumbar cerebrospinal fluid, PROTEOMICS, vol.271, issue.2, pp.541-550, 2005. ,
DOI : 10.1002/pmic.200400934
A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry, PROTEOMICS, vol.33, issue.3, pp.469-473, 2007. ,
DOI : 10.1155/2006/158797
Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry, PROTEOMICS, vol.53, issue.Suppl., pp.4010-4018, 2004. ,
DOI : 10.1016/S0022-510X(99)00019-2
Safety and Acceptability of the Research Lumbar Puncture, Alzheimer Disease & Associated Disorders, vol.19, issue.4, pp.220-225, 2005. ,
DOI : 10.1097/01.wad.0000194014.43575.fd
Abstract, Clinical Chemical Laboratory Medicine, vol.67, issue.6, pp.728-736, 2007. ,
DOI : 10.1007/BF02982039
in cerebrospinal fluid and plasma, Amyloid, vol.2, issue.4, pp.245-258, 2000. ,
DOI : 10.1038/sj.mp.4000313
Interest of major serum protein removal for Surface- Enhanced Laser Desorption/Ionization ? Time Of Flight (SELDI-TOF) proteomic blood profiling, Proteome Sci, 1920. ,
URL : https://hal.archives-ouvertes.fr/hal-00113437
Proteomic Analysis of Cerebrospinal Fluid Changes Related to Postmortem Interval, Clinical Chemistry, vol.52, issue.10, pp.1906-1913, 2006. ,
DOI : 10.1373/clinchem.2006.070508
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease, PROTEOMICS, vol.3, issue.8, pp.1486-1494, 2003. ,
DOI : 10.1002/pmic.200300470
Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process? Proteomics, pp.3060-3065, 2005. ,
DOI : 10.1002/pmic.200402039
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis, Annals of Neurology, vol.13, issue.1, pp.51-57, 1995. ,
DOI : 10.1148/radiology.163.2.3562825
Ubiquitin Ligases in Malignant Lymphoma, Leukemia & Lymphoma, vol.21, issue.7, pp.1329-1339, 2004. ,
DOI : 10.1093/emboj/cdg600
Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers, PROTEOMICS, vol.21, issue.23, pp.6277-6287, 2006. ,
DOI : 10.1007/BF02389687
Attractin Is Elevated in the Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates Glioma Cell Migration, Clinical Cancer Research, vol.12, issue.21, pp.6331-6336, 2006. ,
DOI : 10.1158/1078-0432.CCR-06-1296
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease, Annals of Neurology, vol.63, issue.1, pp.32-40, 1998. ,
DOI : 10.1212/WNL.47.5.1305
Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.70, issue.6, pp.744-748, 2001. ,
DOI : 10.1136/jnnp.70.6.744
Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders, Acta Neurologica Scandinavica, vol.22, issue.3, pp.247-251, 1995. ,
DOI : 10.1161/01.STR.22.10.1254
Clinical and analytical evaluation of an enzyme immunoassay for myelin basic protein in cerebrospinal fluid, Clin. Chem, vol.46, pp.1326-1330, 2000. ,
Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients, Journal of the Neurological Sciences, vol.211, issue.1-2, pp.67-73, 2003. ,
DOI : 10.1016/S0022-510X(03)00066-2
Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls, Journal of Neuroimmunology, vol.31, issue.2, pp.31-91, 1991. ,
DOI : 10.1016/0165-5728(91)90014-X
ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease, Neurology, vol.67, issue.7, pp.1309-1310, 2006. ,
DOI : 10.1212/01.wnl.0000238102.04582.ec
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease, Molecular Brain Research, vol.118, issue.1-2, pp.140-146, 2003. ,
DOI : 10.1016/j.molbrainres.2003.08.005
Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects, Neurological Research, vol.199, issue.2, pp.155-163, 2006. ,
DOI : 10.1038/labinvest.3780116
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients, Neuroreport, vol.13, issue.5, pp.611-615, 2002. ,
DOI : 10.1097/00001756-200204160-00015
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease, Annals of Neurology, vol.20, issue.2, pp.61-120, 2007. ,
DOI : 10.1212/WNL.34.7.939
The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer???s Disease, Reflecting a Common Pathophysiological Process, Dementia and Geriatric Cognitive Disorders, vol.12, issue.4, pp.257-264, 2001. ,
DOI : 10.1159/000051268
Levels of ??-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment, Archives of General Psychiatry, vol.64, issue.6, pp.718-726, 2007. ,
DOI : 10.1001/archpsyc.64.6.718
Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease, PROTEOMICS, vol.4, issue.8, pp.2229-2233, 2004. ,
DOI : 10.1002/pmic.200300799
Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease, BMC Neurology, vol.36, issue.12, 2007. ,
DOI : 10.1161/01.STR.0000189721.31432.26
CSF levels of tau, beta-amyloid(1?42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging, J. Neural. Transm, vol.107, pp.563-579, 2000. ,
The Cerebrospinal Fluid Level of Glial Fibrillary Acidic Protein Is Increased in Cerebrospinal Fluid from Alzheimer???s Disease Patients and Correlates with Severity of Dementia, European Neurology, vol.46, issue.1, pp.35-38, 2001. ,
DOI : 10.1159/000050753
Glial Fibrillary Acidic Protein in the Cerebrospinal Fluid of Patients with Dementia, Dementia and Geriatric Cognitive Disorders, vol.7, issue.5, pp.267-272, 1996. ,
DOI : 10.1159/000106891
Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry, FEBS Letters, vol.231, issue.2, pp.225-228, 1998. ,
DOI : 10.1006/bbrc.1997.6137
Human brain S100?? and S100?? mRNA expression increases with age: Pathogenic implications for Alzheimer's disease, Neurobiology of Aging, vol.17, issue.3, pp.359-363, 1996. ,
DOI : 10.1016/0197-4580(96)00037-1
Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease, Neurochemistry International, vol.39, issue.5-6, pp.409-413, 2001. ,
DOI : 10.1016/S0197-0186(01)00048-1
Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease, Neuroscience Letters, vol.336, issue.3, pp.167-170, 2003. ,
DOI : 10.1016/S0304-3940(02)01257-0
Neuron-Specific Enolase, S-100 Protein, Myelin Basic Protein and Lactate in CSF in Dementia, Dementia and Geriatric Cognitive Disorders, vol.8, issue.3, pp.169-173, 1997. ,
DOI : 10.1159/000106627
Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis, Neurology, vol.68, issue.4, pp.283-287, 2007. ,
DOI : 10.1212/01.wnl.0000252357.30287.1d
Amyloid ??(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease, Neurology, vol.62, issue.9, pp.1580-1584, 2004. ,
DOI : 10.1212/01.WNL.0000123249.58898.E0